• English


Case-Study: Providing highest value for patients with heart disease in the Netherlands

The Netherlands have one of the lowest in-patient average length of stay in Europe for hospitalised people suffering from diseases of the circulatory system. Still, each year almost 40.000 deaths are registered due to cardiovascular diseases.1  To improve quality of care in Dutch hospitals, various cardiac networks have initiated the Dutch Heart Network. The network includes different disease specific groups such as the Atrium fibrillation network, Heart failure network and Coronary Disease network. Among these groups, the network increases collaboration of healthcare professionals and fosters exchange of best practice and mutual comparison between hospitals. While assessing care in participating hospitals on an ongoing basis, the goal is to continuously optimise the quality of care standards across the country and to define and coordinate care pathways for patients with heart disease.

For the definition of quality of care, the Network assesses scientific indicators in a patient-centric approach that provides both highest clinical and financial benefits. The network wants to promote care standards that are of demonstrably high value for patients with heart disease while lowering treatment costs in the long term. The quality model that assesses efficiency and efficacy within the relevant departments of Cardiology is thereby based on the value-based healthcare methodology developed by Professor Michael E. Porter of Harvard Business School. Because the Dutch Heart Network uses the methodology, the quality of care for the patient and the healthcare professional can be continuously optimised – at the benefit of patients, hospitals, and society as a whole.

Read more

1. Eurostat. Cardiovascular disease statistics 2016.

Talk to us

Talk to Abbott Vascular

Want to learn more about our coronary artery disease solutions and our commitment to value-based procurement?

Contact us

Talk to us
Talk to us
Register now
Register now

You Are About To Leave www.valueatheart.com

You are now leaving www.valueatheart.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.


For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labelling for prescriptive information and operating instructions.

This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.